NCT04387721

Brief Summary

MAIN OBJECTIVE: To assess the influence of residual astigmatism on visual acuity in the different lens foci in patients operated on for cataracts with a trifocal intraocular lens implant. SECONDARY OBJECTIVE: To study the influence of residual astigmatism on the visual quality of the patient in the far focus and to determine if there are differences of affectation in the two study groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 29, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 11, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 14, 2020

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

May 14, 2020

Status Verified

May 1, 2020

Enrollment Period

7 months

First QC Date

May 11, 2020

Last Update Submit

May 11, 2020

Conditions

Keywords

CSFContrast SensitivityTrifocal IOL

Outcome Measures

Primary Outcomes (2)

  • Visual Acuity

    Visual acuity will be measured at distance, intermediate distance (67 cm) and near (40 cm). Visual acuities will be obtained with logarithmic notation

    3 months following cataract surgery

  • Contrast Sensitivity Function (CSF)

    Contrast sensitivity will be measured at far, intermediate distance (67 cm) and near (40 cm).

    3 months following cataract surgery

Secondary Outcomes (1)

  • Differences between groups

    3 months following cataract surgery

Study Arms (2)

Trifocal IOL(Finevision IOL, PhysIOL)

We will divide the sample into two groups of patients depending on the IOL implanted First group: FineVision

Other: Kind of trifocal IOL

Trifocal toric IOL (Finevision Toric IOL, PhysIOL)

We will divide the sample into two groups of patients depending on the IOL implanted: Second group: FineVisionToric

Other: Kind of trifocal IOL

Interventions

Patients will be divided between groups based on pre-surgery corneal astigmatism. Group FineVision is made up of patients with corneal astigmatism less than 1 D. Groups FineVision Toric is made up pf patients with corneal astigmatism more than 1.25 D

Also known as: FineVision IOL, FineVision Toric IOL
Trifocal IOL(Finevision IOL, PhysIOL)Trifocal toric IOL (Finevision Toric IOL, PhysIOL)

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The field in which it will carry out the study is a private medical centre. TACIR Ophthalmology clinic is located in the TEKNON Medical Center in the city of Barcelona. The study population will be the patients of the TACIR ophthalmology clinic who will be operated on cataracts and agree to take part in the study.

You may qualify if:

  • Bilateral surgery performed by the same surgeon
  • IOLs implanted IOLs FineVision (MicroF) and FineVision Toric (PodFT)
  • Patients with pre-surgery corneal astigmatism less than 2.5 D
  • Patients whose pupillary diameter in physiological position (conditions of lower photopic pupil) not over 4 mm.

You may not qualify if:

  • Post-surgical refractive residual astigmatisms ≧ 1.55D
  • Previous corneal or intraocular surgeries
  • Active diseases
  • Eye complications during the 3-month follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica Oftalmológica TACIR

Barcelona, 08022, Spain

RECRUITING

MeSH Terms

Conditions

Capsule OpacificationAstigmatism

Condition Hierarchy (Ancestors)

CataractLens DiseasesEye DiseasesRefractive Errors

Study Officials

  • Enrique Ordiñaga-Monreal, OD

    Clinica Oftalmologica TACIR

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Enrique Ordiñaga-Monreal, OD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Optometrist

Study Record Dates

First Submitted

May 11, 2020

First Posted

May 14, 2020

Study Start

July 29, 2019

Primary Completion

March 1, 2020

Study Completion

July 1, 2021

Last Updated

May 14, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations